Advances made within the past decade in the delineation of the structural components of the hepatitis B virus (HBV), including the hepatitis B surface antigen (HBsAg) and the hepatitis B core antigen (HBc), have resulted in the recent commercial availability of new methods of serologic testing. These tests, which include the core antigen antibody (anti-HBc) and the surface antibody (anti-HBs), facilitate the diagnosis and management of this illness by primary care physicians. In addition, a serologic test (anti-HAV) is available to diagnose or exclude hepatitis A, and research efforts are progressing in an attempt to identify a specific marker for non-A non-B hepatitis.
过去十年间,在乙肝病毒(HBV)结构成分的描绘方面取得了进展,其中包括乙肝表面抗原(HBsAg)和乙肝核心抗原(HBc),这使得近期一些新的血清学检测方法得以商业化应用。这些检测包括核心抗原抗体(抗-HBc)和表面抗体(抗-HBs),有助于基层医疗医生对这种疾病进行诊断和管理。此外,有一种血清学检测(抗-HAV)可用于诊断或排除甲型肝炎,并且在识别非甲非乙型肝炎的特异性标志物方面的研究工作也在不断推进。